These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11772261)

  • 1. Strategies for treating HIV-related lipodystrophy.
    García-Viejo MA; Ruíz M; Martínez E
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1443-56. PubMed ID: 11772261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
    Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
    JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
    Currier JS
    AIDS Read; 2000 Mar; 10(3):162-9; discussion 171-4. PubMed ID: 10758016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for lipodystrophy in HIV-positive patients.
    Behrens GM
    Expert Opin Pharmacother; 2008 Jan; 9(1):39-52. PubMed ID: 18076337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wasting and body changes: what do we know so far?
    Gomez E
    Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipodystrophy syndrome in patients with HIV infection: quality of life issues.
    Martínez E; Garcia-Viejo MA; Blanch L; Gatell JM
    Drug Saf; 2001; 24(3):157-66. PubMed ID: 11347720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.
    van der Valk M; Gisolf EH; Reiss P; Wit FW; Japour A; Weverling GJ; Danner SA;
    AIDS; 2001 May; 15(7):847-55. PubMed ID: 11399957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.
    Saint-Marc T; Partisani M; Poizot-Martin I; Bruno F; Rouviere O; Lang JM; Gastaut JA; Touraine JL
    AIDS; 1999 Sep; 13(13):1659-67. PubMed ID: 10509567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego, California, USA 22-25 September 2002.
    Nolan D; Christiansen F
    Expert Opin Drug Saf; 2003 Jan; 2(1):95-101. PubMed ID: 12904128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.
    Carr A; Hudson J; Chuah J; Mallal S; Law M; Hoy J; Doong N; French M; Smith D; Cooper DA;
    AIDS; 2001 Sep; 15(14):1811-22. PubMed ID: 11579243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body habitus changes related to lipodystrophy.
    Sattler F
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S84-90. PubMed ID: 12652376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAART-associated body habitus and metabolic changes, Part 1.
    Liss M; Boyle BA
    AIDS Read; 2000 Nov; 10(11):622, 629-31. PubMed ID: 11186180
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
    Wohl DA
    Top HIV Med; 2004; 12(3):89-93. PubMed ID: 15310940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in lipid metabolism of patients infected by human immunodeficiency virus. A pathogenic hypothesis].
    Rodríguez Vidigal FF; Muñoz Sanz A
    Med Clin (Barc); 2000 Jun; 115(4):145-50. PubMed ID: 10996887
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?
    Behrens GM; Stoll M; Schmidt RE
    Drug Saf; 2000 Jul; 23(1):57-76. PubMed ID: 10915032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.
    Heath KV; Hogg RS; Chan KJ; Harris M; Montessori V; O'Shaughnessy MV; Montanera JS
    AIDS; 2001 Jan; 15(2):231-9. PubMed ID: 11216932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent lipodystrophy findings.
    Proj Inf Perspect; 1999 Sep; (28):9-10. PubMed ID: 11367368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
    Chen D; Misra A; Garg A
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4845-56. PubMed ID: 12414837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.